ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Atropos Health and xCures Advance Artificial Intelligence (AI) to Improve Clinical Decision Making and Patient Outcomes

The Partnership Will Enable Healthcare Providers To Leverage Actionable, Source-Verified Insights For Precision Medicine And Improved Patient Outcomes

Atropos Health, a pioneer in translating clinical real-world data into personalized real-world evidence (RWE) and insights, and xCures, a pioneer in AI-powered healthcare data retrieval, extraction and structuring, announced today a partnership to harness RWE-based insights to support patient care. Through this partnership, the companies will leverage AI, the Atropos Evidence™ Network, and the xCures Platform to develop and deploy rigorously validated prognostic and decision support tools to healthcare providers across the healthcare ecosystem.

The partnership represents a significant leap forward in the use of AI to analyze and deploy RWE. Together, Atropos Health and xCures will develop tools that deliver traceable, source-verified insights from raw clinical notes, analytics, and imaging data—directly into clinical workflows. These tools empower providers to make faster, data-informed decisions tailored to individual patients, helping close the gap between evidence generation and actionable outcomes.

"Removing data silos and doing it in a manner that meets the highest standards of accuracy and compliance aligns with our mission,” said Dr. Brigham Hyde, CEO and co-founder at Atropos Health. "The state of healthcare data, with the use of AI, can rapidly advance precision medicine. Together with xCures, by utilizing the portfolio of Atropos Health services such as GENEVA OS™, Green Button™, Atropos Evidence Network and Alexandria™, shared decision making in clinical settings based on RWE is becoming a reality and an important time-saving tool for physicians."

The xCures platform operates as an AI powered intelligent layer over Health Information Exchanges (HIEs) and Qualified Health Information Networks (QHINs), seamlessly aligning with the standards outlined by the U.S. Department of Health & Human Services under The Trusted Exchange Framework and Common Agreement™ (TEFCA™). Designed to support interoperability and data exchange, the platform ensures compliance while enhancing the utility of healthcare data for personalized treatment planning and clinical decision support. The platform is accessible for Treatment or through Individual Access Services (IAS) as defined under TEFCA. The same solution can be seamlessly integrated with existing organization-owned medical records.

“This partnership empowers providers with real-time access to evidence-based decision support tools developed by Atropos Health and its partners,” said Mika Newton, CEO of xCures. “By integrating Atropos Health’s groundbreaking real-world evidence capabilities with the xCures platform, we enable seamless deployment of these tools directly into clinical workflows. This collaboration ensures that providers can leverage actionable insights at the point of care, improving outcomes and delivering precision medicine at scale.”

Providers gain real-time access to dynamic tools, including checklists, patient-specific summaries, and AI-powered search functionalities, enabling them to rapidly identify actionable insights. Crucially, every data point within the system is traceable and source-verified, whether it originates from raw clinical notes, inferred analytics, or extracted imaging data.

This transparency ensures not only trust in the data but also compliance with the highest standards of medical accuracy.

This announcement comes on the heels of Atropos Health’s new offer of healthcare AI model training, testing, and deployment to members of the Atropos Evidence™ Network. Customers rely on Atropos Health’s portfolio of evidence-generation tools through the federated installation of GENEVA OS™ in their internal cloud data environment. In addition to the Green Button™, GENEVA OS customers can access Alexandria™, a collection of tens of thousands of existing studies, including active clinical trial designs. The existing studies in Alexandria can be rerun on local data, generating novel content and evidence for customer use. All of the solutions enable evidence generation with the same speed-to-insight users have come to expect from Atropos Health.

About Atropos Health

Atropos Health is the developer of GENEVA OS™, the operating system for rapid healthcare evidence across a robust network of real-world data. Healthcare and life science organizations work with Atropos Health to close evidence gaps from bench to bedside, improving individual patient outcomes with data-driven care, expediting research that advances the field of medicine, and more. We aim to transform healthcare with timely, relevant real-world evidence.

To learn more about Atropos Health, visit www.atroposhealth.com or connect through LinkedIn or follow on X (Twitter) @AtroposHealth.

About xCures

Founded in 2018, xCures operates a real-time, healthcare data platform that automatically retrieves medical records from any US care site and normalizes and structures them into a searchable database.

Assisted by artificial intelligence, the platform auto-extracts source-verifiable, configurable checklists and natural language patient summaries to give fast and easy access to the right clinical information needed to deliver care. For more information, contact info@xcures.com or visit www.xcures.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  244.41
+0.00 (0.00%)
AAPL  268.47
+0.00 (0.00%)
AMD  233.54
+0.00 (0.00%)
BAC  53.20
+0.00 (0.00%)
GOOG  279.70
+0.00 (0.00%)
META  621.71
+0.00 (0.00%)
MSFT  496.82
+0.00 (0.00%)
NVDA  188.15
+0.00 (0.00%)
ORCL  239.26
+0.00 (0.00%)
TSLA  429.52
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.